PUBLISHED DATE : Apr 2020 | Pages : 305
Fill out your details & get your free sample
Cardiac Prosthetic Devices Market Size, Share, Trends, Analysis Report by Products (Cardiac Pacemakers and Heart Valve Replacement Devices) End-Users (Hospitals, Specialty Cardiac Centers, and Ambulatory Surgical Centers), and Geography (APAC, Europe, North America, Latin America, and Middle East & Africa) Industry Analysis Report, Regional Outlook, Growth Trends, Competitive Landscape, Share & Forecast, 2020–2025
305 Pages
46 Tables
161 Charts
5 Regions
18 Countries
18 Companies
3 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (Revenue) | USD 19 Billion (2025) |
| CAGR | 14% (2020-2025) |
| Base Year | 2019 |
| Forecast Year | 2020-2025 |
| Market Segments | Products (Cardiac Pacemakers and Heart Valve Replacement Devices) End-Users (Hospitals, Specialty Cardiac Centers, and Ambulatory Surgical Centers) |
| Geographic Analysis | APAC, Europe, North America, Latin America, and Middle East & Africa |
| Countries Covered | Spain, Germany, Italy, France, UK, US, Canada, South Korea, China, Japan, Australia, India, Brazil, Argentina, Mexico, Turkey, Saudi Arabia, South Africa |
The global cardiac prosthetic devices market size will be valued at USD 19 billion in 2025 and is expected to grow at a significant rate during the forecast period. The growing incidence of arrhythmia caused by arterial fibrillation (AF), structural heart diseases, especially heart valve diseases worldwide, is the major factor contributing to the growth. As the occurrence of AF in the general population in developed countries is between 1.5% and 3%, and in the elderly population around 20%, the market is likely to increase its market share considerably. Moreover, the prevalence of several valvular disorders such as aortic stenosis (AS), mitral regurgitation, pulmonary stenosis, tricuspid regurgitation, and congenital heart defects has increased at a significant rate over the past few years globally.
The demand for transcatheter valve replacement techniques is growing at a phenomenal rate due to the growing awareness of the devices, favorable reimbursement coverage, and increased prevalence of high-risk patients. The increasing mortality rate due to severe heart valve diseases, especially in the elderly population, is a key global concern among healthcare providers. Therefore, to address this concern, medical practitioners prefer to perform heart valve replacement surgeries with transcatheter technique among high-risk patients. Hence, the increase in the target population, coupled with a growing risk of severe heart valve diseases, is expected to increase the demand for transcatheter surgical techniques.
This research report includes a detailed segmentation by
The heart valve replacement devices market is growing at a healthy rate. An increase in the aging population and the presence of a large pool of patients with heart valve diseases is a major factor in driving the segment growth. The market is expected to grow significantly in the coming years due to the growing demand for transcatheter heart valve replacement procedures, especially TAVR, and the availability of next-generation cardiac prosthetic valves.
The growth of the transcatheter heart valves can mainly be attributed to superior safety and efficacy features, coupled with the growing prevalence of heart valve diseases globally. The penetration is high in developed countries such as the US, Germany, Japan, France, the UK, Italy, and Spain. Similarly, advances in heart valve repair & replacement technologies have helped to boost unit sales of tissue heart valves as the improvement in tissue valves has increased durability, which makes them suitable for implantation in young patients. However, the share of mitral tissue valve replacement procedures is expected to increase during the forecast period as end-users are opting for TAVR heart procedures over aortic tissue valve replacement procedures. The mechanical heart valves segment is likely to account for a slower rate than the tissue and transcatheter heart valves segments. The demand for mechanical heart valves is declining, especially in developed economies, due to high risks and complications of cardiac prosthetic devices and the rapid evolution of advanced tissue and transcatheter heart valves with higher safety and efficacy. However, the global mechanical heart valves market is growing due to a steady increase in demand for mechanical heart valves in developing and emerging countries as these devices are relatively less expensive and offer long-life expectancy.
Advances in technology are improving the safety and efficacy of pacemakers. The conventional cardiac pacemaker segment is growing at a healthy rate due to the high uptake of technologically advanced implantable pacemakers, such as leadless and MRI compatible pacemakers. CRT-P device enhances the heart’s effectiveness and increases the blood flow compared to standard pacemakers. They also improve heart failure symptoms such as shortness of breath, fatigue, and exercise intolerance. CRT-P is an advanced type of pacemaker that provides certain additional advantages such as sensing of heart rate and delivering shock accurately.
Moreover, another prime function of the CRT-P device is to minimize the future chances of heart failure. Hence, the adoption of CRT-Ps is increasing at a significant rate. Besides, favorable public and private reimbursement coverage across the globe is projected to boost the adoption of CRT-Ps, resulting in the overall growth of the global cardiac pacemaker market.
Hospitals are the major end-users for the cardiac prosthetic devices market as they perform a high number of implantation procedures. The increasing number of heart ailments and the growing implantations in the hospitals are fueling the growth of the segment. Healthcare professionals in hospitals use advanced cardiovascular prosthetic devices such as implantable pacemakers, CRT-Ps, transcatheter, tissue, and mechanical heart valves as a treatment procedure of cardiac diseases. The specialty cardiology center segment is expected to grow at an absolute growth of over 140% during the forecast period. The segment is likely to grow at a faster rate than hospitals as they are equipped with better infrastructure for cardiology care. Specialty cardiac centers provide exclusive healthcare services to patients with suspected or diagnosed heart diseases. These centers are solely dedicated to treating patients that are suffering from several ailments such as arrhythmia and structural heart diseases. Ambulatory Surgery Centers (ASC) are growing at a promising rate as they are modern healthcare settings equipped with sophisticated healthcare infrastructure. This segment is expected to witness healthy growth, especially in developed countries, due to the growing popularity of procedures such as pacemaker implants and TAVR over conventional open surgical techniques for implanting cardiac prosthetic heart devices.
The growth in North America is mainly attributed to the high incidence of cardiac diseases such as heart valve disease and abnormal heart rhythms, the availability of advanced healthcare infrastructure and constant technological innovations, and growing acceptance for transcatheter and other MI procedures. A strong preference for MI procedures is one of the key reasons for high market share. Europe is the second-largest cardiac prosthetic devices market, particularly Western Europe, has a well-established healthcare infrastructure with access to advanced healthcare services, especially for replacement procedures for heart diseases such as arrhythmia and heart valve diseases. Also, the increasing incidence of abnormal heart rhythm, heart valve disease, rapid adoption of advanced cardiac assist devices, and high healthcare expenditures are driving the cardiac prosthetic devices market growth in Europe.
APAC is growing at a significant rate and is expected to grow during the forecast period. The presence of a large pool of patient population, improvements in healthcare infrastructure, and increased healthcare expenditure are the factors contributing to the growth. Further, the increasing prevalence of heart diseases is a key factor driving the cardiac prosthetic devices market shares.
Brazil, Mexico, and Argentina are the major revenue contributors to Latin America. Cardiovascular diseases (CVDs) are the major cause of mortality in the region. The presence of a large pool of the patient population that requires cardiac prosthetic devices, an increase in government initiatives and funding on healthcare, and improvements in healthcare infrastructure are the main factors driving the growth.
Turkey, Saudi Arabia, and South Africa are the major revenue contributors to the MEA region. The MEA cardiac prosthetic devices market is growing due to the presence of a large pool of patients that require heart valve replacement devices, pacemakers, and CRT-Ps, an increase in government initiatives and healthcare funding, and improvements in healthcare infrastructure. Moreover, the market in MEA is expected to grow due to the increase in healthcare spending, improved literacy rates, increasing awareness about healthcare treatments, and a large middle-class population with high spending power.
The global cardiac prosthetic devices market is highly competitive and characterized by the presence of a few key players and a significant number of other prominent players offering a wide range of advanced and innovative devices. The market is witnessing rapid technological advancements and is significantly affected by new product launches. Abbott, BIOTRONIK, Boston Scientific, Edwards Lifesciences, and Medtronic are the major players with dominant shares in the market. The dominant presence of major players is attributable to their strong presence and endorsement for their products due to the availability of abundant clinical data/evidence regarding safety and efficacy.
Key Vendors
By Products
By End-user
By Geography
The global cardiac prosthetic devices market size to cross USD 19 billion by 2020, growing at a CAGR of over 14% during the forecast period.
As the occurrence of AF in the general population in developed countries is between 1.5% and 3%, and in the elderly population around 20%, the market is likely to increase its market share considerably.
The growth in North America is mainly attributed to the high incidence of cardiac diseases such as heart valve disease and abnormal heart
Medtronic, Boston Scientific, Abbott, Edwards Lifesciences, and BIOTRONIK are the leading vendors in the market.
The following factors are likely to contribute to the growth of the cardiac prosthetic devices market during the forecast period:
Base Year: 2019
Forecast Year: 2020–2025
The study considers the present scenario of the cardiac prosthetic devices market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent companies operating in the market.
Key Vendors
Other Vendors
Market Segmentation by Products
Market Segmentation by End-user
Market Segmentation by Geography
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of the study
4.4 Market Segments
4.4.1 Market Segmentation by Product
4.4.2 Market Segmentation by End-User
4.4.3 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Arrhythmia and Heart Valve Diseases: An Overview
7.1.1 Background
7.1.2 Cardiac Pacemakers
7.1.3 Heart Valve Replacement Devices for Heart Valve Diseases
7.1.4 Cardiac Prosthetic Devices Market Snapshot
8 Market Dynamics
8.1 Market Growth Enablers
8.1.1 Rising Patient Pool with Arrhythmia & Heart Valve Diseases
8.1.2 Increasing Demand for Transcatheter Heart Valve Replacement Procedures
8.1.3 New Product Approvals/Launches
8.1.4 Technological Advancements
8.2 Market Restraints
8.2.1 High Cost of Cardiac Prosthetic Devices & Implantation
8.2.2 Risks and Complications Associated with Cardiac Prosthetic Devices
8.2.3 Stringent Government Regulations and Product Recalls
8.3 Market Opportunities and Trends
8.3.1 Advent of Leadless Cardiac Pacemakers
8.3.2 High Growth Potential of Transcatheter Mitral Valve Replacement Devices
8.3.3 Promising Investigational Cardiac Prosthetic Devices
8.3.4 Growing Demand for Automated Cardiac Prosthetic Devices Integrated with Remote Monitoring Platforms
8.3.5 Emergence of Next-generation Heart Valve Replacement Devices
8.3.6 Strategic Acquisitions
9 Market Landscape
9.1 Market Overview
9.2 Market Size & Forecast
9.3 Five Forces Analysis
9.3.1 Threat of New Entrants
9.3.2 Bargaining Power of Suppliers
9.3.3 Bargaining Power of Buyers
9.3.4 Threat of Substitutes
9.3.5 Competitive Rivalry
10 Product
10.1 Market Snapshot & Growth Engine
10.2 Market Overview
11 Heart Valve Replacement Devices
11.1 Market Snapshot & Growth Engine
11.2 Market Overview
11.2.1 Market Size & Forecast
11.3 Product Segmentation
11.4 Transcatheter Heart Valves
11.4.1 Market Overview
11.4.2 Market Size & Forecast
11.5 Tissue Heart Valves
11.5.1 Market Overview
11.5.2 Market Size & Forecast
11.6 Mechanical Heart Valves
11.6.1 Market Overview
11.6.2 Market Size & Forecast
11.7 Geographic Segmentation
11.7.1 North America: Market Size & Forecast
11.7.2 Europe: Market Size & Forecast
11.7.3 APAC: Market Size & Forecast
11.7.4 Latin America: Market Size & Forecast
11.7.5 Middle East & Africa: Market Size & Forecast
12 Cardiac Pacemakers
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.2.1 Market Size & Forecast
12.3 Product Segmentation
12.4 Conventional Cardiac Pacemakers
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.5 Cardiac Resynchronization Therapy Pacemakers (crt-ps)
12.5.1 Market Overview
12.5.2 Market Size & Forecast
12.6 Geographic Segmentation
12.6.1 North America: Market Size & Forecast
12.6.2 Europe: Market Size & Forecast
12.6.3 APAC: Market Size & Forecast
12.6.4 Latin America: Market Size & Forecast
12.6.5 Middle East & Africa: Market Size & Forecast
13 End-User
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Hospitals
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.4 Specialty Cardiac Centers
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.5 ASCs
13.5.1 Market Overview
13.5.2 Market Size & Forecast
14 Geography
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
15 North America
15.1 Market Overview
15.2 Market Size & Forecast
15.3 Key Countries
15.3.1 US: Market Size & Forecast
15.3.2 Canada: Market Size & Forecast
16 Europe
16.1 Market Overview
16.2 Market Size & Forecast
16.3 Key Countries
16.3.1 Germany: Market Size & Forecast
16.3.2 France: Market Size & Forecast
16.3.3 UK: Market Size & Forecast
16.3.4 Italy: Market Size & Forecast
16.3.5 Spain: Market Size & Forecast
17 APAC
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Key Countries
17.3.1 Japan: Market Size & Forecast
17.3.2 China: Market Size & Forecast
17.3.3 India: Market Size & Forecast
17.3.4 Australia: Market Size & Forecast
17.3.5 South Korea: Market Size & Forecast
18 Latin America
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Key Countries
18.3.1 Brazil: Market Size & Forecast
18.3.2 Mexico: Market Size & Forecast
18.3.3 Argentina: Market Size & Forecast
19 Middle East & Africa
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Key Countries
19.3.1 Turkey: Market Size & Forecast
19.3.2 Saudi Arabia: Market Size & Forecast
19.3.3 South Africa: Market Size & Forecast
20 Competitive Landscape
20.1 Competition Overview
20.1.1 Medtronic
20.1.2 Boston Scientific
20.1.3 Abbott
20.1.4 Edwards Lifesciences
20.1.5 Biotronik
20.2 Market Share Analysis: Cardiac Pacemakers
20.3 Market Share Analysis: Heart Valve Replacement Devices
21 Key Company Profiles
21.1 Medtronic
21.1.1 Business Overview
21.1.2 Major Product Offerings
21.1.3 Key Strengths
21.1.4 Key Strategies
21.1.5 Key Opportunities
21.2 Boston Scientific
21.2.1 Business Overview
21.2.2 Major Product Offerings
21.2.3 Key Strengths
21.2.4 Key Strategies
21.2.5 Key Opportunities
21.3 Abbott
21.3.1 Business Overview
21.3.2 Major Product Offerings
21.3.3 Key Strengths
21.3.4 Key Strategies
21.3.5 Key Opportunities
21.4 Edwards Lifesciences
21.4.1 Business Overview
21.4.2 Major Product Offerings
21.4.3 Key Strengths
21.4.4 Key Strategies
21.4.5 Key Opportunities
21.5 BIOTRONIK
21.5.1 Business Overview
21.5.2 Major Product Offerings
21.5.3 Key Strengths
21.5.4 Key Strategies
21.5.5 Key Opportunities
22 Other Prominent Vendors
22.1 Braile Biomédica
22.1.1 Business Overview
22.1.2 Key Product Offerings
22.2 CryoLife
22.2.1 Business Overview
22.2.2 Key Product Offerings
22.3 Labcor Laboratórios
22.3.1 Business Overview
22.3.2 Key Product Offerings
22.4 Lepu Medical
22.4.1 Business Overview
22.4.2 Key Product Offerings
22.5 Lifetech Scientific
22.5.1 Business Overview
22.5.2 Key Product Offerings
22.6 LivaNova
22.6.1 Business Overview
22.6.2 Key Product Offerings
22.7 MicroPort Scientific
22.7.1 Business Overview
22.7.2 Key Product Offerings
22.8 Meril Life Sciences
22.8.1 Business Overview
22.8.2 Key Product Offerings
22.9 MEDICO
22.9.1 Business Overview
22.9.2 Key Product Offerings
22.10 Shree Pacetronix
22.10.1 Business Overview
22.10.2 Key Product Offerings
22.11 TTK Healthcare
22.11.1 Business Overview
22.11.2 Key Product Offerings
22.12 VENUS MEDTECH
22.12.1 Business Overview
22.12.2 Key Product Offerings
22.13 Vitatron
22.13.1 Business Overview
22.13.2 Key Product Offerings
23 Report Summary
23.1 Key Takeaways
23.2 Strategic Recommendations
23.3 Quantitative Summary
23.3.1 Product
23.3.2 End-User
23.3.3 Geography
24 Appendix
24.1 Abbreviations
List of Exhibits
Exhibit 1 Segmentation of Global Cardiac Prosthetic Devices Market
Exhibit 2 Market Size Calculation Approach 2019
Exhibit 3 Evolution of Cardiac Pacemakers 1950−2016
Exhibit 4 Indications for Permanent Pacemaker Implantation
Exhibit 5 Global Cardiac Prosthetic Devices Market Share by Geography 2019 (%)
Exhibit 6 Global Cardiac Prosthetic Devices Market Share by Product 2019 (%)
Exhibit 7 Impact of Rising Patient Pool with Arrhythmia & Heart Valve Diseases
Exhibit 8 Increasing Age Contributing to the Increasing Prevalence of Abnormal Heartbeats
Exhibit 9 Mortality Rate of Atrial Fibrillation Among Men in Developing & Developed Countries 1990-2015 (Per 100,000 population)
Exhibit 10 Risk Factors Associated with Abnormal Heart Rhythms
Exhibit 11 Age-Adjusted Prevalence of Atrial Fibrillation Among Men & Women in Developing & Developed Countries (Per 100,000 population)
Exhibit 12 Percentage of Patients Diagnosed with Mild, Moderate, and Severe Valve Diseases
Exhibit 13 Prevalence of Valve Diseases in Different Age Groups
Exhibit 14 Prevalence of Aortic Regurgitation in Different Age groups
Exhibit 15 Five Year Survival Rate of Major Life-threatening Disorders
Exhibit 16 Impact of Increasing Demand for Transcatheter Heart Valve Replacement Procedures
Exhibit 17 Impact of New Product Approvals/Launches
Exhibit 18 List of Cardiac Prosthetic Devices Approved/Launched Recently
Exhibit 19 Impact of Technological Advancements
Exhibit 20 Advancements in Pacemaker Technology from 1950 to 2016
Exhibit 21 Evolution of Battery Usage in Cardiac Pacemakers from 1950s to 1970s
Exhibit 22 Impact of High Cost of Cardiac Prosthetic Devices & Implantation
Exhibit 23 Percentage Breakdown of Various Cost Components in Cardiac Pacemaker Implantation
Exhibit 24 Breakdown of Pacemaker Implantation Cost in US ($)
Exhibit 25 Impact of Risks & Complications Associated with Cardiac Prosthetic Devices
Exhibit 26 Most Common Cardiac Pacemaker Complications
Exhibit 27 Comparison of Major & Minor Complications Post Cardiac Pacemaker Implantation Up to 6 Months Follow-up
Exhibit 28 Major & Minor Complications Associated with Cardiac Pacemaker Implantation
Exhibit 29 Major and Minor Complication Risk percentage for different age group patients
Exhibit 30 Most Common Cardiac Pacemaker Complications
Exhibit 31 Impact of Stringent Government Regulations and Product Recalls
Exhibit 32 “Protecting Patients, Promoting Public Health” Recommends
Exhibit 33 Impact of Advent of Leadless Cardiac Pacemakers
Exhibit 34 Impact of High Growth Potential of Transcatheter Mitral Valve Replacement Devices
Exhibit 35 Impact of Promising Investigational Cardiac Prosthetic Devices
Exhibit 36 Cardiac Prosthetic Pipeline Devices
Exhibit 37 Impact of Growing Demand for Automated Cardiac Prosthetic Devices Integrated with Remote Monitoring Platforms
Exhibit 38 Factors to be Considered for Rhythmic Management (RM) Systems
Exhibit 39 Impact of Emergence of Next-generation Heart Valve Replacement Devices
Exhibit 40 Impact of Strategic Acquisitions
Exhibit 41 Global Cardiac Prosthetic Devices Market 2019−2025 ($ billion)
Exhibit 42 Global Cardiac Prosthetic Devices Market by Geography
Exhibit 43 Global Cardiac Prosthetic Devices Market by Product
Exhibit 44 Global Cardiac Prosthetic Devices Market by End-user
Exhibit 45 Five Force Analysis 2019
Exhibit 46 Incremental Growth by Product 2019 & 2025
Exhibit 47 Global Cardiac Prosthetic Devices Market by Product
Exhibit 48 Incremental Growth by Heart Valve Replacement Devices 2019 & 2025
Exhibit 49 Global Heart Valve Replacement Devices Market 2019−2025 ($ billion)
Exhibit 50 Global Heart Valve Replacement Devices Market by Product
Exhibit 51 Global Heart Valve Replacement Devices Market by Product: Incremental Growth
Exhibit 52 Global Heart Valve Replacement Devices Market by Product: Absolute Growth
Exhibit 53 Global Heart Valve Replacement Devices Market by Product 2019−2025 ($ million)
Exhibit 54 Global Heart Valve Replacement Devices Market by Product 2019−2025 (%)
Exhibit 55 Estimated Number of TAVR Procedure Worldwide 2012−2025
Exhibit 56 Global Transcatheter Heart Valves Market: Incremental & Absolute Growth
Exhibit 57 Global Transcatheter Heart Valves Market 2019−2025 ($ million)
Exhibit 58 Global Tissue Heart Valves Market: Incremental & Absolute Growth
Exhibit 59 Global Tissue Heart Valves Market 2019−2025 ($ million)
Exhibit 60 Global Mechanical Heart Valves Market 2019−2025 ($ million)
Exhibit 61 North America Heart Valve Replacement Devices Market 2019−2025 ($ million)
Exhibit 62 Europe Heart Valve Replacement Devices Market 2019−2025 ($ million)
Exhibit 63 APAC Heart Valve Replacement Devices Market 2019−2025 ($ million)
Exhibit 64 Latin America Heart Valve Replacement Devices Market 2019−2025 ($ million)
Exhibit 65 Middle East & Africa Heart Valve Replacement Devices Market 2019−2025 ($ million)
Exhibit 66 Incremental Growth by Cardiac Pacemakers 2019 & 2025
Exhibit 67 Global Cardiac Pacemakers Market 2019−2025 ($ billion)
Exhibit 68 Global Cardiac Pacemakers Market by Product
Exhibit 69 Global Cardiac Pacemakers Market by Product: Incremental Growth
Exhibit 70 Global Cardiac Pacemakers Market by Product: Absolute Growth
Exhibit 71 Global Cardiac Pacemakers Market by Product 2019−2025 ($ million)
Exhibit 72 Global Cardiac Pacemakers Market by Product 2019−2025 (%)
Exhibit 73 Global Conventional Cardiac Pacemakers Market: Incremental & Absolute Growth
Exhibit 74 Global Conventional Cardiac Pacemakers Market 2019−2025 ($ million)
Exhibit 75 Global CRT-Ps Market: Incremental & Absolute Growth
Exhibit 76 Global CRT-Ps Market 2019−2025 ($ million)
Exhibit 77 North America Cardiac Pacemakers Market 2019−2025 ($ million)
Exhibit 78 Europe Cardiac Pacemakers Market 2019−2025 ($ million)
Exhibit 79 APAC Cardiac Pacemakers Market 2019−2025 ($ million)
Exhibit 80 Latin America Cardiac Pacemakers Market 2019−2025 ($ million)
Exhibit 81 Middle East & Africa Cardiac Pacemakers Market 2019−2025 ($ million)
Exhibit 82 Incremental Growth by End-user 2019 & 2025
Exhibit 83 Global Cardiac Prosthetic Devices Market by End-user
Exhibit 84 Global Cardiac Prosthetic Devices Market by End-user: Incremental Growth
Exhibit 85 Global Cardiac Prosthetic Devices Market by End-user: Absolute Growth
Exhibit 86 Global Cardiac Prosthetic Devices Market by End-User 2019−2025 ($ million)
Exhibit 87 Global Cardiac Prosthetic Devices Market by End-User 2019−2025 (%)
Exhibit 88 Global Cardiac Prosthetic Devices Market by Hospitals: Incremental & Absolute Growth
Exhibit 89 Global Cardiac Prosthetic Devices Market by Hospitals 2019−2025 ($ million)
Exhibit 90 Global Cardiac Prosthetic Devices Market by Specialty Cardiac Centers: Incremental & Absolute Growth
Exhibit 91 Global Cardiac Prosthetic Devices Market by Specialty Cardiac Centers 2019−2025 ($ million)
Exhibit 92 Global Cardiac Prosthetic Devices Market by ASCs: Incremental & Absolute Growth
Exhibit 93 Global Cardiac Prosthetic Devices Market by ASCs 2019−2025 ($ million)
Exhibit 94 Incremental Growth by Geography 2019 & 2025
Exhibit 95 Global Cardiac Prosthetic Devices Market by Geography
Exhibit 96 Global Cardiac Prosthetic Devices Market by Geography 2019: Key Countries ($ million)
Exhibit 97 Global Cardiac Prosthetic Devices Market by Geography: Incremental Growth
Exhibit 98 Global Cardiac Prosthetic Devices Market by Geography: Absolute Growth
Exhibit 99 Global Cardiac Prosthetic Devices Market by Geography 2019−2025 ($ million)
Exhibit 100 Global Cardiac Prosthetic Devices Market by Geography 2019−2025 (%)
Exhibit 101 Global Cardiac Prosthetic Devices Market in North America in 2019
Exhibit 102 North America Cardiac Prosthetic Devices Market: Absolute & Incremental Growth
Exhibit 103 Cardiac Prosthetic Devices Market in North America 2019–2025 ($ million)
Exhibit 104 Incremental Growth in North America 2019 & 2025
Exhibit 105 Cardiac Prosthetic Devices Market in US 2019–2025 ($ million)
Exhibit 106 Cardiac Prosthetic Devices Market in Canada 2019–2025 ($ million)
Exhibit 107 European Country Wise Pacemaker Implanted Per Million Inhabitants 2009−2013
Exhibit 108 Cardiac Prosthetic Devices Market in Europe 2019
Exhibit 109 Cardiac Prosthetic Devices Market in Europe: Incremental & Absolute Growth
Exhibit 110 Cardiac Prosthetic Devices Market in Europe 2019–2025 ($ million)
Exhibit 111 Absolute Number of Pacemaker Implantation Centers in EU 2013
Exhibit 112 Incremental Growth in Europe 2019 & 2025
Exhibit 113 Cardiac Prosthetic Devices Market in Germany 2019–2025 ($ million)
Exhibit 114 Cardiac Prosthetic Devices Market in France 2019–2025 ($ million)
Exhibit 115 Cardiac Prosthetic Devices Market in UK 2019–2025 ($ million)
Exhibit 116 Cardiac Prosthetic Devices Market in Italy 2019–2025 ($ million)
Exhibit 117 Distribution of Insurance Modality (%)
Exhibit 118 Cardiac Prosthetic Devices Market in Spain 2019–2025 ($ million)
Exhibit 119 APAC Cardiac Prosthetic Devices Market in 2019
Exhibit 120 APAC Cardiac Prosthetic Devices Market: Incremental & Absolute Growth
Exhibit 121 Payment by Governments for Cardiac Pacemakers Implantation in Various APAC Countries (%)
Exhibit 122 Cardiac Prosthetic Devices Market in APAC 2019–2025 ($ million)
Exhibit 123 Incremental Growth in APAC 2019 & 2025
Exhibit 124 Cardiac Prosthetic Devices Market in Japan 2019–2025 ($ million)
Exhibit 125 Provincial Reimbursement Policy in China
Exhibit 126 Cardiac Prosthetic Devices Market in China 2019–2025 ($ million)
Exhibit 127 Cost Comparison of Cardiac Pacemakers in India & US ($)
Exhibit 128 Cardiac Prosthetic Devices Market in India 2019–2025 ($ million)
Exhibit 129 Cardiac Prosthetic Devices Market in Australia 2019–2025 ($ million)
Exhibit 130 Cardiac Prosthetic Devices Market in South Korea 2019–2025 ($ million)
Exhibit 131 Latin America Cardiac Prosthetic Devices Market 2019
Exhibit 132 Latin America Cardiac Prosthetic Devices Market: Incremental & Absolute Growth
Exhibit 133 Cardiac Prosthetic Devices Market in Latin America 2019–2025 ($ million)
Exhibit 134 Incremental Growth in Latin America 2019 & 2025
Exhibit 135 Number of Implantations Performed in Various Developing Countries Per Million
Exhibit 136 Reimbursement Cost in Brazil ($)
Exhibit 137 Cardiac Prosthetic Devices Market in Brazil 2019–2025 ($ million)
Exhibit 138 Cardiac Prosthetic Devices Market in Mexico 2019–2025 ($ million)
Exhibit 139 Cardiac Prosthetic Devices Market in Argentina 2019–2025 ($ million)
Exhibit 140 Middle East & Africa Cardiac Prosthetic Devices Market in 2019
Exhibit 141 Middle East & Africa Cardiac Prosthetic Devices Market: Incremental & Absolute Growth
Exhibit 142 Sub-Saharan Africa Increasing Cardiac Pacing (%) 2004−2015
Exhibit 143 Cardiac Prosthetic Devices Market in Middle East & Africa 2019–2025 ($ million)
Exhibit 144 Incremental Growth in Middle East & Africa 2019 & 2025
Exhibit 145 Cardiac Prosthetic Devices Market in Turkey 2019–2025 ($ million)
Exhibit 146 Cardiac Prosthetic Devices Market in Saudi Arabia 2019–2025 ($ million)
Exhibit 147 Cardiac Prosthetic Devices Market in South Africa 2019–2025 ($ million)
Exhibit 148 Global Cardiac Pacemakers Market: Vendors Shares
Exhibit 149 Global Heart Valve Replacement Devices Market: Vendors Shares
Exhibit 150 Medtronic: R&D Expenditure 2017-2019 ($ million)
Exhibit 151 Medtronic: Revenue by Business Segment 2018−2019 ($ million)
Exhibit 152 Medtronic: Revenue by Geography 2019 (%)
Exhibit 153 Boston Scientific: Revenue by Business Segment 2017−2018 ($ million)
Exhibit 154 Boston Scientific R&D Expenditure 2016-2018 ($ million)
Exhibit 155 Boston Scientific: Revenue by Geography 2019 (%)
Exhibit 156 Abbott: Revenue by Business Segment 2017−2018 ($ billion)
Exhibit 157 Abbott: R&D Expenditure 2016−2018 ($ million)
Exhibit 158 Abbott: Revenue by Geography 2018 (%)
Exhibit 159 Edwards Lifesciences: R&D Expenditure 2016−2018 ($ million)
Exhibit 160 Edwards Lifesciences: Revenue by Product Type 2017−2018 ($ million)
Exhibit 161 Edwards Lifesciences: Revenue by Geography 2019 (%)
List of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2019
Table 3 Comparison of Mechanical & Tissue Heart Valves
Table 4 Major Transcatheter-based Valve Replacement Devices
Table 5 Life Span of Few Popular Cardiac Pacemakers
Table 6 Incidence Rate of Various Complications Post Cardiac Pacemaker Implantation
Table 7 Major Product Recalls
Table 8 Comparison of Micra and Nanostim Leadless Cardiac Pacemakers
Table 9 Major Transcatheter MVR Clinical Trials
Table 10 Recent Acquisitions in Global Cardiac Prosthetic Devices Market
Table 11 Vendors Offering Transcatheter Heart Valves
Table 12 List of Major Tissue Heart Valves
Table 13 List of Major Mechanical Heart Valves
Table 14 Prominent Vendors Offering Implantable Cardiac Pacemakers
Table 15 List of Popular Conventional Cardiac Pacemakers
Table 16 List of Popular CRT-Ps
Table 17 Global Cardiac Pacemakers Market Top Vendors Ranking 2019
Table 18 Global Heart Valve Replacement Devices Top Vendors Ranking 2019
Table 19 Medtronic: Key Product Offerings
Table 20 Boston Scientific: Key Product Offerings
Table 21 Abbott: Product Offerings
Table 22 Edwards Lifesciences: Product Offerings
Table 23 BIOTRONIK: Key Product Offerings
Table 24 Braile Biomédica: Key Product Offerings
Table 25 CryoLife: Key Product Offerings
Table 26 Labcor Laboratórios: Key Product Offerings
Table 27 Lepu Medical: Key Product Offerings
Table 28 Lifetech Scientific: Key Product Offerings
Table 29 LivaNova: Key Product Offerings
Table 30 MicroPort Scientific: Key Product Offerings
Table 31 Meril Life Sciences: Key Product Offerings
Table 32 MEDICO: Key Product Offerings
Table 33 Shree Pacetronix: Key Product Offerings
Table 34 TTK Healthcare: Key Product Offerings
Table 35 VENUS MEDTECH: Key Product Offerings
Table 36 Vitatron: Key Product Offerings
Table 37 Global Cardiac Prosthetic Devices Market by Product ($ million)
Table 38 Global Cardiac Prosthetic Devices Market by Product (%)
Table 39 Global Heart Valve Replacement Devices Market by Product ($ million)
Table 40 Global Heart Valve Replacement Devices Market by Product (%)
Table 41 Global Cardiac Pacemakers Market by Product ($ million)
Table 42 Global Cardiac Pacemakers Market by Product (%)
Table 43 Global Cardiac Prosthetic Devices Market by End-user ($ million)
Table 44 Global Cardiac Prosthetic Devices Market by End-user (%)
Table 45 Global Cardiac Prosthetic Devices Market by Geography ($ million)
Table 46 Global Cardiac Prosthetic Devices Market by Geography (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
